| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Internet and Businesses Online > Ezine Publishing > What Media Picks Up Articles from Online Article Submission Sites? |
|
Just Other Articles - What Media Picks Up Articles from Online Article Submission Sites?
Many online article writers put their creativity to work writing articles and putting them onlin According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product e. An easy way to do this is to find an online article submission site, which specializes in “Ez ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ne Articles” or companies, which produce online newsletters sent out by email. You can find such lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. sites by searching; Ezine Articles on the various search engines. Having written many online ar here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe icles and I have had my articles picked up everywhere. Ezines, Magazines, Newspapers, Industry J d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ournals and used as web content. I have had people insert my articles into Blogs, Forums, Chatro ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc ms online, as well as into stories of fiction and books. They have been put into E-books, regula easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi books and educational literature. Used by NGOs to advance causes and political organizations to nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically drive traffic and controversy or propel an issue. You name it. If you are looking to drive traf and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ fic or something of that nature. My objective is none of what is listed above, just sharing my i ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi eas and observations rather than running around with them in my head. JP Morgan said "know a lot ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a say little" and yes I did that for 20 years. Now I have taken a new tact; "know a lot; tell a l dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod t" I suppose such online article sites work differently for different people. I like it actuall cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin y, I think it is very cool. But I imagine of the 170,000 articles online on one particular onlin tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen article submission site that well, some do not get read much or used much elsewhere. And of the t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel 20,000 authors who contribute, some probably do a lot better than others? That's it basically. ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust y goals there are not making money, promoting myself or any company, just expressing views, prop y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products elling thought and sharing observations really? So where as yes I have been getting that done in . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de a very big way; results will vary for those who participate, but I very strongly recommend using elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip such source for marketing, services, products or just plain ideas like me. Consider this in 2006 tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:What Most Employers Don't Want You to Know When They Talk Salary Perfromance: Firing Incompetent Employees - How To Do It Right
|